Literature DB >> 11356410

Effects on thrombin generation of the platelet glycoprotein IIb/IIIa inhibitors abciximab versus tirofiban during coronary intervention.

J A Ambrose1, R Doss, J M Geagea, M C Hawkey, S Duvuri, K Giedd, A Dominguez, J Coppola, T H Nguyen, V Palla, R S Barua, D C Saha.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11356410     DOI： 10.1016/s0002-9149(01)01506-5

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN： 0002-9149            Impact factor:   2.778


× No keyword cloud information.
  3 in total

Review 1.  Heparin dose during percutaneous coronary intervention: how low dare we go?

Authors:  G Niccoli; A P Banning
Journal:  Heart       Date:  2002-10       Impact factor: 5.994

Review 2.  Abciximab: an updated review of its therapeutic use in patients with ischaemic heart disease undergoing percutaneous coronary revascularisation.

Authors:  Tim Ibbotson; Jane K McGavin; Karen L Goa
Journal:  Drugs       Date:  2003       Impact factor: 9.546

3.  Heparin anticoagulation in patients undergoing off-pump and on-pump coronary bypass surgery.

Authors:  Kenichi A Tanaka; Vinod H Thourani; Willis H Williams; Peggy G Duke; Jerrold H Levy; Robert A Guyton; John D Puskas
Journal:  J Anesth       Date:  2007-08-01       Impact factor: 2.078
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.